Modeling and targeting general and chromosome-specific aneuploidy in cancer
Genes & Development · 28.07.2025
DOI: 10.1101/gad.352766.125 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genes & Development, online erschienen am 28.07.2025. Verfasst von Aleah Goldberg und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Systems Genetics, Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, New…. Hauptthemen laut MEDLINE: Aneuploidy, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDDK NIH HHS, NHGRI NIH HHS.
Abstract (Originalsprache)
Throughout the last century, aneuploidy has been cemented as a hallmark of cancer. Although the association of aneuploidy with tumorigenesis has been well established, the role of these genetic imbalances in tumor formation has only recently begun to be elucidated. Advancements in genomics have revealed the complexity and context dependence of the effect of aneuploidy on cancer growth, while developments in genetic editing have allowed for proper modeling of specific aneuploidies. In this review, we discuss the key factors to consider when studying the role of aneuploidy in cancer and the tools that are available to do so. We then highlight recent studies that establish phenotypic contributions of aneuploidy to tumorigenicity. In particular, we highlight how general aneuploidy and chromosomal instability affect the tumor microenvironment and how specific chromosomal alterations, including the loss of chromosome 9p and the gain of chromosomes 8q and 1q, influence tumor behavior and therapeutic responses. Finally, we emphasize the potential of targeting aneuploidy-induced vulnerabilities to improve cancer treatment outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Systems Genetics, Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, New York 10016, USA.
- Institute for Systems Genetics, Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, New York 10016, USA teresa.davoli@nyulangone.org tdavoli@gmail.com.
Förderung
- NCI NIH HHS
- NIDDK NIH HHS
- NHGRI NIH HHS
- National Institutes of Health
- Pershing Square Sohn Prize for Young Investigators in Cancer Research
Zitieren
APA
Goldberg, A., Trifas, M., & Davoli, T. (2025). Modeling and targeting general and chromosome-specific aneuploidy in cancer. Genes & Development. https://doi.org/10.1101/gad.352766.125
Vancouver
Goldberg A, Trifas M, Davoli T. Modeling and targeting general and chromosome-specific aneuploidy in cancer. Genes & Development. 2025. doi:10.1101/gad.352766.125
BibTeX
@article{Goldberg2025,
author = {Goldberg, Aleah and Trifas, Maria and Davoli, Teresa},
title = {Modeling and targeting general and chromosome-specific aneuploidy in cancer},
journal = {Genes & Development},
year = {2025},
doi = {10.1101/gad.352766.125}
}
EUVIMED